Keyphrases
Hypertrophic Cardiomyopathy
83%
Peripartum Cardiomyopathy
75%
Heart Transplantation
57%
Heart Transplant
41%
Critically Ill Patients
35%
Pathophysiology
34%
Pregnancy-associated Cardiomyopathy
33%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
33%
T Cell Subsets
31%
Heart Failure
30%
Defibrillator
29%
Rotary Blood Pump
25%
Mechanical Support
25%
Cardiac Failure
25%
Immune Activation
25%
Pump Control
25%
Intravenous Milrinone
25%
Therapeutic Implications
25%
Cannula Tip
25%
Systolic Heart Failure
25%
Support Strategies
25%
Implantable Defibrillator
25%
Mechanical Circulatory Support
25%
Monocytes
25%
Natural Killer Cells
25%
Circulating T Cells
25%
Prolactin
25%
Implantable Devices
25%
Multicenter Research
25%
Patients with Heart Failure
25%
Refractory Cardiogenic Shock
25%
Myocardial Recovery
25%
Device-independent
25%
Cellular Immune Response
25%
Early Development
25%
Single Center
25%
Post-transplant Outcomes
25%
Metabolic Pathway
25%
Medical Treatment
25%
Dysregulation
25%
Cholesterol Metabolism
25%
Cardiomyopathy
20%
Septal Reduction Therapy
17%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
16%
Ventricular Tachycardia
16%
Conductance Measurement
16%
Milrinone
16%
Conductance
16%
Ventricular Size
16%
Echocardiography
16%
Medicine and Dentistry
Hypertrophic Cardiomyopathy
100%
Peripartum Cardiomyopathy
75%
Congestive Heart Failure
63%
Heart Transplantation
57%
Myocardial Disease
49%
Combination Therapy
49%
Assisted Circulation
43%
Heart Graft
41%
Pathophysiology
34%
T Cell Subset
30%
Immunity
27%
Defibrillator
27%
Left Ventricular Assist Device
25%
Transplantation
25%
Cardiogenic Shock
25%
Systolic Heart Failure
25%
Heart Failure
25%
Prolactin
25%
Milrinone
25%
Patient Monitoring
25%
Natural Killer Cell
25%
Developmental Stage
25%
Cannula
25%
Medical Implant
25%
Prospective Study
25%
Proteomics
25%
Cholesterol Metabolism
25%
Diseases
23%
Cardiac Dysrhythmia
22%
Inotropism
16%
Terminal Illness
16%
Health Care Cost
16%
Heart Left Ventricle Ejection Fraction
15%
Implantable Automatic Defibrillator
15%
CD3 Antigen
15%
Obstruction
12%
Diastolic Function
12%
Genetic Screening
12%
Lactic Acid
12%
Sudden Death
12%
Intensive Care Unit
12%
Echocardiography
12%
Shock (Circulatory)
12%
Physical Examination
12%
Cannulation
12%
Cardiovascular Disease
12%
Mavacamten
11%
Cytotoxic T-Cell
10%
Ventricular Tachycardia
10%
Intra-Aortic Balloon Pump
8%